Galderma Group AG (GDERF)
219.80
+14.05
(+6.83%)
USD |
OTCM |
Aug 25, 16:00
Galderma Group Price : 219.80 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 219.05 | 219.80 | 212.71 | 219.80 | 8.000 |
| Aug 24, 2026 | 213.65 | 221.55 | 205.75 | 205.75 | 28.00 |
| Aug 21, 2026 | 221.55 | 222.30 | 221.55 | 222.30 | 10.00 |
| Aug 20, 2026 | 205.75 | 205.75 | 205.01 | 205.01 | 18.00 |
| Aug 19, 2026 | 218.05 | 218.80 | 211.50 | 218.80 | 19.00 |
| Aug 18, 2026 | 198.60 | 212.15 | 198.60 | 212.15 | 7.000 |
| Aug 17, 2026 | 205.05 | 218.05 | 205.05 | 205.05 | 39.00 |
| Aug 14, 2026 | 221.65 | 222.40 | 221.65 | 222.40 | 22.00 |
| Aug 13, 2026 | 210.70 | 210.70 | 210.70 | 210.70 | 5640.00 |
| Aug 12, 2026 | 210.70 | 210.70 | 210.70 | 210.70 | 1.000 |
| Aug 11, 2026 | 228.55 | 228.55 | 228.55 | 228.55 | 0.000 |
| Aug 10, 2026 | 215.75 | 228.55 | 215.75 | 228.55 | 4.000 |
| Aug 07, 2026 | 225.75 | 225.75 | 219.95 | 219.95 | 827.00 |
| Aug 06, 2026 | 225.00 | 225.00 | 214.95 | 214.95 | 8.000 |
| Aug 05, 2026 | 217.75 | 217.75 | 208.85 | 208.85 | 15.00 |
| Aug 04, 2026 | 225.00 | 225.00 | 215.75 | 215.75 | 11.00 |
| Aug 03, 2026 | 222.85 | 222.85 | 209.55 | 209.55 | 11.00 |
| Jul 31, 2026 | 225.00 | 225.75 | 211.75 | 225.75 | 40.00 |
| Jul 30, 2026 | 225.00 | 225.00 | 215.15 | 225.00 | 6431.00 |
| Jul 29, 2026 | 223.55 | 223.55 | 223.55 | 223.55 | 22.00 |
| Jul 28, 2026 | 224.15 | 224.15 | 224.15 | 224.15 | 16293.00 |
| Jul 27, 2026 | 203.20 | 225.75 | 203.20 | 225.00 | 165.00 |
| Jul 24, 2026 | 217.65 | 217.65 | 212.25 | 212.25 | 11308.00 |
| Jul 23, 2026 | 213.65 | 213.65 | 200.65 | 213.65 | 85.00 |
| Jul 22, 2026 | 209.60 | 212.80 | 209.60 | 212.80 | 3657.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 159.98 |
| Roche Holding AG | 58.47 |
| Addex Therapeutics Ltd. | 3.90 |
| Oculis Holding AG | 12.96 |
| Sandoz Group AG | 92.06 |
Price Related Metrics
| PE Ratio | 60.03 |
| PS Ratio | 8.792 |
| Price to Free Cash Flow | 48.83 |
| Earnings Yield | 1.67% |
| Market Cap | 51.25B |
| Operating PE Ratio | 47.45 |
| Normalized PE Ratio | 56.04 |